Literature DB >> 2957133

Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis.

A Lobo-Yeo, L Alviggi, G Mieli-Vergani, B Portmann, A P Mowat, D Vergani.   

Abstract

We found a significant increase of activated circulating T lymphocytes expressing interleukin 2 receptor (IL-2r) (mean +/- s.e.m. 11.0 +/- 1.1%) or DR antigen (5.0 +/- 0.49%) in patients with autoimmune chronic active hepatitis (CAH) starting in childhood when compared to healthy controls (0.14 +/- 0.09%, P less than 0.001 and 2.8 +/- 0.06%, P less than 0.01). Patients with liver disorders due to Wilson's disease (IL-2r 0.64 +/- 0.25%, DR 3.5 +/- 0.22%) or alpha-1-antitrypsin deficiency (IL-2r 0.1 +/- 0.06%, DR 2.8 +/- 0.35%) had levels similar to controls. Levels of both IL-2r and DR positive T lymphocytes were higher in patients with uncontrolled CAH (IL-2r 18.0 +/- 1.01%; DR 6.3 +/- 0.78%) than in patients with inactive disease (IL-2r 3.2 +/- 1.4%, P less than 0.001; DR 3.0 +/- 0.13%, P less than 0.01). In patients with active disease levels of IL-2r positive cells were higher than DR positive cells (P less than 0.001). Only 21% of activated T cells coexpressed the two markers of activation. Sixty-seven percent of IL-2r positive T lymphocytes were helper/inducer and 25% suppressor/cytotoxic, while 66% of the DR positive T cells were suppressor/cytotoxic and 31% helper/inducer. The finding that the highest levels of activated T lymphocytes are present in patients with uncontrolled CAH suggests that these cells are involved in its pathogenesis. The preferential increase of activated helper/inducer cells might explain the enhanced immune reactivity characteristic of autoimmune CAH.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957133      PMCID: PMC1542558     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

2.  Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies.

Authors:  M De Waele; C Thielemans; B K Van Camp
Journal:  N Engl J Med       Date:  1981-02-19       Impact factor: 91.245

3.  Aberrations of suppressor T cells in human graft-versus-host disease.

Authors:  E L Reinherz; R Parkman; J Rappeport; F S Rosen; S F Schlossman
Journal:  N Engl J Med       Date:  1979-05-10       Impact factor: 91.245

4.  Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression.

Authors:  E L Reinherz; P C Kung; J M Pesando; J Ritz; G Goldstein; S F Schlossman
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

5.  Subpopulations of the T4+ inducer T cell subset in man: evidence for an amplifier population preferentially expressing Ia antigen upon activation.

Authors:  E L Reinherz; C Morimoto; A C Penta; S F Schlossman
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

6.  Immune interferon in the circulation of patients with autoimmune disease.

Authors:  J J Hooks; H M Moutsopoulos; S A Geis; N I Stahl; J L Decker; A L Notkins
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

7.  HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies.

Authors:  I R Mackay; B D Tait
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

8.  Chronic hepatitis: a problem for the pathologist.

Authors:  P J Scheuer
Journal:  Histopathology       Date:  1977-01       Impact factor: 5.087

9.  Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization.

Authors:  D T Yu; R J Winchester; S M Fu; A Gibofsky; H S Ko; H G Kunkel
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

10.  Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells.

Authors:  H S Ko; S M Fu; R J Winchester; D T Yu; H G Kunkel
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  19 in total

Review 1.  Mitochondrial antigens and antibodies in primary biliary cirrhosis.

Authors:  P Butler; F Valle; A K Burroughs
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 2.  Autoimmune hepatitis.

Authors:  G Mieli-Vergani; D Vergani
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

3.  Exacerbated autoimmune hepatitis successfully treated with leukocytapheresis and bilirubin adsorption therapy.

Authors:  K Sawada; K Ohnishi; T Kosaka; S Chikano; A Egashira; M Okui; S Shintani; M Wada; K Nakasho; T Shimoyama
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

4.  Anti-lymphocytic antibodies in autoimmune chronic active hepatitis starting in childhood.

Authors:  P T Donaldson; M J Hussain; G Mieli-Vergani; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

5.  Remission of experimental autoimmune hepatitis is associated with antigen-specific and non-specific immunosuppression.

Authors:  A W Lohse; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

6.  Autoimmune chronic active hepatitis in a family.

Authors:  S Hodges; A Lobo-Yeo; P Donaldson; M S Tanner; D Vergani
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

7.  Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.

Authors:  R Y Tun; M Peakman; L Alviggi; M J Hussain; S S Lo; M Shattock; D A Pyke; G F Bottazzo; D Vergani; R D Leslie
Journal:  BMJ       Date:  1994-04-23

8.  Elevation of activated gamma delta T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease.

Authors:  L Wen; M Peakman; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

9.  Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro.

Authors:  H Löhr; U Treichel; T Poralla; M Manns; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

Review 10.  Aetiopathogenesis of autoimmune hepatitis.

Authors:  Diego Vergani; Giorgina Mieli-Vergani
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.